Estrella Immunopharma
Yahoo Finance • 3 months ago
ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders
STAMFORD, Conn., July 08, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. (“Estrella”). This investigation is to determine whether Estrella’s b... Full story
Yahoo Finance • 7 months ago
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
EMERYVILLE, Calif., March 23, 2026--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to... Full story
- GILD